Skip to main content

Table 4 Univariate logistic regression to determine predictors of selected cardiovascular disease risk factors

From: The prevalence of selected non-communicable disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge sub-district, Mpumalanga province

VariablesSmokingAlcohol consumptionHypertensionOverweightObesityWaist Circumference
Age
 18–34 yearsReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
  ≥ 35 years1.5 (0.5–4.8) a0.3 (0.2–0.6)**1.6 (1.3–2.1)***1.5 (0.8–3.1) a0.7 (0.4–1.4) a0.97 (0.53–1.78) a
Gender
 FemaleReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
 Male18.9 (0.5–47.4)***3.6 (2.1–6.3)***1.5 (0.9–2.4) a0.9 (0.5–1.9) a0.09 (0.03–0.3)***0.3 (0.3–0.5)***
Educational status
 HighReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
 Low0.9 (0.6–1.5) a0.7 (0.5–1.1) a0.8 (0.6–1.1) a1.6 (1.2–2.3)**1.0 (0.6–1.9) a1.1 (0.8–1.6) a
Marital status
 MarriedReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
 Single3.6 (1.3–9.9)*0.9 (0.4–1.9) a1.7 (0.9–3.0) a0.8 (0.4–1.7) a0.7 (0.3–1.5) a0.8 (0.4–1.6) a
 Cohabiting3.9 (1.3–11.9)*0.9 (0.4–2.1) a1.1 (0.5–2.4) a0.3 (0.1–1.0)*0.7 (0.2–1.9) a0.7 (0.3–1.9) a
 Divorced5.6 (1.4–22.2)*0.7 (0.2–3.1) a2.2 (0.7–6.0) a0.2 (0.02–1.2) a3.1 (0.9–10.4) a1.6 (0.5–5.1) a
 Separated2.2 (0.4–11.6) a0.2 (0.02–1.4) a2.2 (0.8–5.9) a0.8 (0.2–2.6) a0.6 (0.2–2.6) a1.1 (0.4–3.7) a
 Widowed1.2 (0.2–6.3) a0.4 (0.1–1.6) a2.7 (1.2–6.0)*1.0 (0.4–2.6) a1.0 (0.3–2.9) a1.6 (0.6–4.1) a
Work status
 WorkingReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
 Not working0.8 (0.5–1.1)a2.8 (0.7–10.8) a0.9 (0.7–1.1)a0.08 (0.02–0.3)a1.2 (0.3–5.1) a0.8 (2.1–2.9) a
ART Regimen
 FDCReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
 Dumiva and efavirenz0.9 (0.3–2.2)a0.3 (0.1–0.7)*2.1 (1.1–3.8)*0.8 (0.4–1.7)a1.7 (0.8–3.3)a2.1 (1.2–3.8)*
 Dumiva and alluvia0.6 (0.1–2.7)a0.7 (0.2–1.9)a3.3 (1.4–7.5)**1.4 (0.5–3.4)a0.8 (0.3–2.6)a1.2 (0.5–2.8)a
 Efavirenz and lamividine3.7 (0.2–59.7)a2.6 (0.2–42.4)a
 Tenamine and neverapine0.4 (0.05–3.2)a0.3 (0.1–1.5)a1.7 (0.7–4.5)a0.7 (0.2–2.5)a1.6 (0.6–4.8)a1.9 (0.7–4.9)a
 Alluvia and tenefovir1.9 (0.3–11.7)a2.4 (0.4–15.0)a1.2 (0.1–10.6)a1.7 (0.3–10.6)a
Duration of ART
  ≥ 5 yearsReference (1)Reference (1)Reference (1)Reference (1)Reference (1)Reference (1)
 3–4 years0.8 (0.3–2.5)a0.6 (0.2–1.6)a1.6 (0.7–3.5)a0.7 (0.3–1.5)a1.6 (0.8–3.2)a0.8 (0.2–4.2)a
  ≤ 2 years1.2 (0.5–2.9)a1.4 (0.7–3.0)a0.6 (0.3–1.3)a1.7 (0.9–3.0)a0.9 (0.4–1.7)a0.3 (0.04–2.5)a
  1. Values are reported as odds ratios (95%CI); * significant at p < 0.05; ** significant at p < 0.005; *** significant at p < 0.001, aNot significant
\